Position in RDHL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,811
+$1,053 QoQ
Shares Held
5,116
+91.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RDHL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. RDHL ranks #48 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,229,009 | $145,281,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
122,486 | $72,631,748 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
303,820 | $40,025,246 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,268,203 | $30,348,097 | |
| 5 | VTRS |
Viatris Inc
|
1,941,082 | $26,224,017 | |
| 6 | ALKS |
Alkermes plc.
|
449,531 | $15,895,416 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
194,563 | $14,757,603 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
643,856 | $13,366,450 |
All Filings in RDHL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,811 | 5,116 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,758 | 2,678 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,836 | 1,768 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,429 | 1,768 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,692 | 1,388 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $7,439 | 1,198 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $8,557 | 979 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||